Migrasome Therapeutics
Zijing
About Migrasome Therapeutics
Migrasome Therapeutics is an innovative drug research and development company based on new biological discoveries.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $14.0M
- Funding stage: Seed
- Last round: Angel (Jul 2023)
- Website: migrasome.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/migrasome-therapeutics-80352 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.